<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Dyspepsia ‚Äì Unidentified Cause (Adult) | Quick Reference Algorithm</title>
  <style>
    /* ----- Base / Reset ----- */
    :root {
      --bg: #ffffff;
      --bg-muted: #f6f9fc;
      --panel: #ffffff;
      --ink: #1b2733;
      --ink-muted: #4b5563;
      --brand: #2a7de1;
      --brand-2: #64b5f6;
      --accent: #ffcc80;
      --success: #2e7d32;
      --warning: #c77800;
      --danger: #b71c1c;
      --border: #e5e7eb;
      --shadow: 0 10px 24px rgba(31, 41, 55, 0.08), 0 2px 6px rgba(31, 41, 55, 0.06);
    }
    * { box-sizing: border-box; }
    html, body { height: 100%; }
    body {
      margin: 0;
      background: var(--bg);
      color: var(--ink);
      font-family: system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      line-height: 1.4;
    }
    a { color: var(--brand); text-decoration: none; }
    h1, h2, h3 { line-height: 1.2; margin: 0 0 .4rem; }
    h1 { font-size: clamp(1.6rem, 2.5vw + .8rem, 2.4rem); }
    h2 { font-size: clamp(1.2rem, 1.2vw + .8rem, 1.4rem); }
    h3 { font-size: 1.05rem; color: var(--ink-muted); font-weight: 600; }
    p { margin: .2rem 0 .8rem; color: var(--ink-muted); }
    ul { margin: .2rem 0 .8rem; padding-left: 1.1rem; }
    .container { max-width: 1100px; margin: 0 auto; padding: 2rem 1rem 3rem; }

    /* ----- Header ----- */
    .hero {
      background: linear-gradient(180deg, #f0f6ff 0%, #ffffff 65%);
      border-bottom: 1px solid var(--border);
    }
    .hero-inner { display: grid; gap: 1rem; align-items: center; grid-template-columns: 1fr; }
    .badge { display: inline-flex; align-items: center; gap: .5rem; padding: .25rem .6rem; border: 1px solid var(--border); border-radius: 999px; background: var(--bg);
      font-size: .85rem; color: var(--ink-muted); }
    .title-row { display: flex; align-items: center; justify-content: space-between; flex-wrap: wrap; gap: .75rem; }
    .meta { color: var(--ink-muted); font-size: .95rem; }

    /* ----- Grid / Cards ----- */
    .grid { display: grid; gap: 1rem; grid-template-columns: repeat(12, 1fr); }
    .card {
      grid-column: span 12;
      background: var(--panel);
      border: 1px solid var(--border);
      border-radius: 16px;
      box-shadow: var(--shadow);
      padding: 1.1rem 1.1rem 1rem;
    }
    .card h2 { margin-bottom: .35rem; }
    .card .sub { font-size: .95rem; color: var(--ink-muted); margin-bottom: .6rem; }

    @media (min-width: 880px) {
      .col-4 { grid-column: span 4; }
      .col-6 { grid-column: span 6; }
      .col-8 { grid-column: span 8; }
      .col-12 { grid-column: span 12; }
    }

    /* ----- Chips / Pills ----- */
    .pill { display: inline-block; padding: .2rem .6rem; border-radius: 999px; border: 1px solid var(--border); background: var(--bg-muted); font-size: .85rem; margin: .15rem .35rem .35rem 0; }

    /* ----- Callouts ----- */
    .callout { border-left: 4px solid var(--brand); background: #f4f9ff; padding: .75rem .9rem; border-radius: 10px; }
    .callout.warn { border-left-color: var(--warning); background: #fff7e6; }
    .callout.danger { border-left-color: var(--danger); background: #fff1f0; }
    .callout.success { border-left-color: var(--success); background: #f1fbf3; }

    /* ----- Flow Steps ----- */
    .steps { display: grid; gap: .8rem; }
    .step { display: grid; gap: .45rem; border: 1px dashed var(--border); border-radius: 12px; padding: .75rem; background: var(--bg); }
    .step .head { display: flex; align-items: center; gap: .5rem; }
    .num { width: 28px; height: 28px; display: inline-grid; place-items: center; border-radius: 999px; background: var(--brand); color: #fff; font-weight: 700; font-size: .95rem; }

    /* ----- Tables ----- */
    .table { width: 100%; border-collapse: collapse; }
    .table th, .table td { border: 1px solid var(--border); padding: .55rem .6rem; text-align: left; }
    .table th { background: #f1f6ff; font-weight: 600; }
    .table caption { text-align: left; color: var(--ink-muted); margin-bottom: .4rem; }

    /* ----- Footer / Print ----- */
    .footer { color: var(--ink-muted); font-size: .9rem; display: flex; flex-wrap: wrap; gap: .5rem; justify-content: space-between; margin-top: .8rem; }
    .btn-print { padding: .55rem .8rem; border: 1px solid var(--border); border-radius: 10px; background: var(--bg); cursor: pointer; font-weight: 600; }

    @media print {
      body { background: #fff; }
      .hero, .btn-print { display:none !important; }
      .card { box-shadow: none; break-inside: avoid; page-break-inside: avoid; }
      .container { padding: 0; }
      a { color: inherit; text-decoration: none; }
    }
  </style>
</head>
<body>
  <header class="hero">
    <div class="container hero-inner">
      <div class="title-row">
        <div>
          <span class="badge">Adult ‚â•18y ¬∑ Primary Care Quick Reference</span>
          <h1>Dyspepsia ‚Äì Unidentified Cause</h1>
          <div class="meta">Clean, one-page algorithm for fast decision-making during consultations.</div>
        </div>
        <button class="btn-print" onclick="window.print()" aria-label="Print algorithm">üñ®Ô∏è Print</button>
      </div>
    </div>
  </header>

  <main class="container">
    <section class="grid">
      <!-- Red Flags / Initial Assessment -->
      <article class="card col-6">
        <h2>1) Initial Assessment</h2>
        <p class="sub">Identify red flags, contributing factors, and opportunities for self-management.</p>
        <div class="callout danger" role="note">
          <strong>Urgent endoscopy (‚â§2 weeks)</strong> if any of: <em>dysphagia</em>; age ‚â•55 <em>with weight loss</em>; persistent vomiting; GI bleeding/iron-deficiency anaemia; epigastric mass; strong family history of upper GI cancer.
        </div>
        <h3>History & Exam</h3>
        <ul>
          <li>Symptom pattern (‚â•4 weeks), impact on QoL; check weight/BMI, anaemia signs, abdominal mass/tenderness.</li>
          <li>Medication review: NSAIDs, aspirin/antiplatelets, steroids, bisphosphonates, CCBs, nitrates, theophyllines, TCA, Œ≤/Œ±-blockers.</li>
          <li>Consider differentials: cardiac, hepatobiliary, pancreatic, coeliac, lactose intolerance, IBS, SIBO.</li>
        </ul>
        <h3>Lifestyle Advice</h3>
        <div>
          <span class="pill">Weight loss if overweight</span>
          <span class="pill">Avoid triggers (coffee, chocolate, tomatoes, fatty/spicy)</span>
          <span class="pill">Smaller meals; avoid late eating (3‚Äì4h before bed)</span>
          <span class="pill">Stop smoking</span>
          <span class="pill">Limit alcohol</span>
          <span class="pill">Address stress/anxiety/depression</span>
        </div>
      </article>

      <!-- Initial Management Choices -->
      <article class="card col-6">
        <h2>2) Initial Management</h2>
        <p class="sub">Choose one primary strategy based on clinical judgement.</p>
        <div class="steps">
          <div class="step">
            <div class="head"><span class="num">A</span><strong>Empirical PPI</strong></div>
            <ul>
              <li>Full-dose PPI for <strong>4 weeks</strong> (see dosing below).</li>
            </ul>
          </div>
          <div class="step">
            <div class="head"><span class="num">B</span><strong>Test &amp; Treat H. pylori</strong></div>
            <ul>
              <li><strong>Urea breath</strong> or <strong>stool antigen</strong> (ensure ‚â•2w off PPI, ‚â•4w off antibiotics).
              </li>
              <li>If <strong>positive</strong> ‚Üí start eradication (Section 3).</li>
            </ul>
          </div>
          <div class="callout" role="note">
            If symptoms persist/return after the chosen strategy, <strong>switch</strong> to the other strategy and reassess adherence, meds, and lifestyle.
          </div>
        </div>
      </article>

      <!-- PPI Dosing Table -->
      <article class="card col-12">
        <h2>PPI Dosing (Adults)</h2>
        <table class="table" aria-label="PPI dosing">
          <thead>
            <tr><th>PPI</th><th>Full/Standard</th><th>Low (on-demand)</th><th>Double</th></tr>
          </thead>
          <tbody>
            <tr><td>Omeprazole</td><td>20 mg OD</td><td>10 mg OD</td><td>40 mg OD</td></tr>
            <tr><td>Lansoprazole</td><td>30 mg OD</td><td>15 mg OD</td><td>30 mg BD</td></tr>
            <tr><td>Pantoprazole</td><td>40 mg OD</td><td>20 mg OD</td><td>40 mg BD</td></tr>
            <tr><td>Rabeprazole</td><td>20 mg OD</td><td>10 mg OD</td><td>20 mg BD</td></tr>
            <tr><td>Esomeprazole</td><td>20 mg OD</td><td>‚Äî</td><td>40 mg OD</td></tr>
          </tbody>
        </table>
        <p class="sub">Dose 30 mins before breakfast (and before evening meal if twice-daily).</p>
      </article>

      <!-- First-Line HP Eradication -->
      <article class="card col-12">
        <h2>3) H. pylori Eradication &mdash; First Line (7 days)</h2>
        <div class="grid" style="gap:.8rem; grid-template-columns: repeat(12, 1fr);">
          <div class="col-6" style="grid-column: span 6;">
            <h3>Standard Triple</h3>
            <ul>
              <li><strong>PPI BD</strong> + <strong>Amoxicillin 1 g BD</strong> + <strong>Clarithromycin 500 mg BD</strong> <em>or</em> <strong>Metronidazole 400 mg BD</strong>.</li>
            </ul>
          </div>
          <div class="col-6" style="grid-column: span 6;">
            <h3>Penicillin Allergy</h3>
            <ul>
              <li><strong>PPI BD</strong> + <strong>Clarithromycin 500 mg BD</strong> + <strong>Metronidazole 400 mg BD</strong>.</li>
            </ul>
          </div>
          <div class="col-12" style="grid-column: span 12;">
            <h3>Penicillin Allergy &amp; Prior Clarithromycin Exposure</h3>
            <ul>
              <li><strong>Quadruple</strong>: <strong>PPI BD</strong> + <strong>Metronidazole 400 mg BD</strong> + <strong>Tetracycline 500 mg QID</strong> + <strong>Bismuth (subsalicylate) QID</strong>.</li>
            </ul>
          </div>
        </div>
        <div class="callout success" role="note">Emphasise adherence; tailor regimen to prior antibiotic exposure.</div>
      </article>

      <!-- Persistent / Recurrent Symptoms -->
      <article class="card col-6">
        <h2>4) If Symptoms Persist / Recur</h2>
        <ul>
          <li>Switch to the alternate initial strategy if not yet tried.</li>
          <li>Reinforce adherence &amp; lifestyle; review drugs and consider stopping NSAIDs/aspirin where possible (or add gastroprotection).</li>
          <li>Consider <strong>H2RA</strong> if inadequate response to PPI.</li>
          <li>Think differentials (cardiac/hepatobiliary/pancreatic/coeliac/IBS/SIBO).</li>
        </ul>
        <div class="callout warn" role="note">Do <strong>not</strong> routinely re-test for <em>H. pylori</em> after first-line therapy unless: poor compliance; test done within 2w of PPI or 4w of abx; NSAID/aspirin indicated (esp. prior PUD); family history gastric cancer; severe/persistent/recurrent symptoms; or patient-request.</div>
      </article>

      <!-- HP Retesting & Second-Line -->
      <article class="card col-6">
        <h2>5) Retesting &amp; Second-Line Regimens</h2>
        <ul>
          <li>If indicated, re-test ‚â•4 weeks (ideally 8) after therapy; ensure ‚â•2w off PPI &amp; ‚â•4w off antibiotics.</li>
          <li>If positive ‚Üí choose an alternative regimen to those previously used:</li>
        </ul>
        <h3>Second-Line Options (7 days)</h3>
        <ul>
          <li><strong>PPI BD</strong> + <strong>Amoxicillin 1 g BD</strong> + <strong>Clarithromycin 500 mg BD</strong> <em>or</em> <strong>Metronidazole 400 mg BD</strong> (whichever not used first).</li>
          <li>If both clarithromycin &amp; metronidazole used: <strong>PPI BD</strong> + <strong>Amoxicillin 1 g BD</strong> + <strong>Levofloxacin 250 mg BD</strong> <em>or</em> <strong>Tetracycline 500 mg QID</strong>.</li>
          <li><strong>Penicillin allergy</strong>: <strong>PPI BD</strong> + <strong>Metronidazole 400 mg BD</strong> + <strong>Levofloxacin 250 mg BD</strong> (if not used before).</li>
          <li>Allergy + prior levofloxacin: <strong>Quadruple</strong> (<strong>PPI BD</strong> + <strong>Bismuth QID</strong> + <strong>Metronidazole 400 mg BD</strong> + <strong>Tetracycline 500 mg QID</strong>).</li>
        </ul>
        <p class="sub"><em>Note:</em> Systemic fluoroquinolones should be reserved when other commonly recommended antibiotics are inappropriate (MHRA safety advice).</p>
      </article>

      <!-- Referral -->
      <article class="card col-12">
        <h2>6) When to Refer</h2>
        <div class="grid" style="gap:.8rem; grid-template-columns: repeat(12, 1fr);">
          <div class="col-6">
            <h3>Urgent</h3>
            <ul>
              <li>Any red flags (Section 1).</li>
            </ul>
          </div>
          <div class="col-6">
            <h3>Routine / Gastro Review</h3>
            <ul>
              <li>Refractory/recurrent symptoms despite optimal primary care management.</li>
              <li>Failure of <strong>second-line</strong> eradication.</li>
              <li>Limited antibiotic options (hypersensitivity, high local resistance, extensive prior exposure).</li>
            </ul>
          </div>
        </div>
        <div class="callout" role="note">If endoscopy planned: stop acid suppression ‚â•2 weeks before; use antacid/alginate PRN.</div>
      </article>

      <!-- Long-term Management -->
      <article class="card col-12">
        <h2>7) Long‚Äëterm Management</h2>
        <ul>
          <li>Annual review if on long-term PPI/H2RA; use lowest effective dose; consider PRN regimen; attempt step-down/stop where appropriate.</li>
          <li>Self-treatment with antacid/alginate can help intermittently but is not for continuous long-term use.</li>
        </ul>
      </article>
    </section>

    <section class="footer">
      <div>
        <strong>Notes:</strong> PPI/H2RA may mask symptoms prior to endoscopy‚Äîstop ‚â•2 weeks before any planned procedure. Consider bone health and hypomagnesaemia risks with long-term PPIs.
      </div>
      <div>Designed for light theme &amp; printing ‚Ä¢ Last updated: Sep¬†2025</div>
    </section>
  </main>
</body>
</html>